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Editorial on the Research Topic
Functional Relevance of Tetraspanins in the Immune System
Tetraspanins, members of the superfamily of four-transmembrane proteins, are evolutionary
highly conserved membrane proteins that function as membrane-organizers (1–3). Immune cells
express thousands of different membrane proteins (including adhesion receptors, uptake receptors,
major histocompatibility molecules, enzymes, cytokine receptors, and others) that all need to
be correctly localized in time and space at the cell surface. Tetraspanins specifically interact in
cis with various immune receptors by forming multimolecular complexes (tetraspanin-enriched
microdomains, TEMs) that can initiate immune cell signaling (4, 5). Thereby, tetraspanins control
fundamental immune cell functions, including adhesion, pathogen uptake, immunological synapse
formation, and proliferation. Tetraspanin-deficiency in mouse models and patients results in
different immunological defects (6). This Review Topic provides a timely overview of the biological
importance of tetraspanin-induced membrane organization in the immune system and the latest
insights in targeting tetraspanins as novel drugs for infectious disease and cancer.
Immune cells are the fastest migrating cells in our body that depend on tight cooperation
of different adhesion molecules (integrins, selectins, immunoglobulin superfamily members) and
chemokine receptors to patrol for pathogens and reach inflammatory sites. For integrins, it has
been well-established that clustering (avidity) and conformational change (affinity) both underlie
activation. Tetraspanins are well-defined interaction partners for integrins (2, 7) that control
adhesion andmigration of lymphocytes, dendritic cells (8), and neutrophils (9). Yeung et al. discuss
the functional roles of tetraspanins in leukocytes and endothelial cells during transmigration from
the circulation into tissues. Most tetraspanins (CD9, CD37, CD81, and CD151) promote lymphoid
and myeloid cell adhesion and migration through functional interaction with β1 and β2 integrins.
In this regard, CD9 regulates the adhesive capacity of integrin α5β1 by modulating its association
with the membrane protease ADAM17 on the cell surface (Machado-Pineda et al.). CD9 is also
required for myeloid cell migration in a murine colitis model shown by decreased neutrophil
and macrophage infiltration in colonic tissue from CD9-deficient mice (Saiz et al.). In contrast,
tetraspanin CD82 in dendritic cells reduces cell motility through regulation of cytoskeletal proteins
(e.g., RhoA). It is not known whether CD82 directly interacts with Rho GTPases, in line with
the identified interaction between CD81 and Rac1 (10), or alternatively that CD82 regulates the
cytoskeleton via interacting with ezrin/radixin/moesin (ERM) proteins. Besides directly interacting
with adhesion molecules, tetraspanins have been reported to control the activity of membrane
metalloproteases that can induce cleavage of adhesion receptors. For example, CD9 inhibits the
shedding activity of ADAM17 and thereby supports ALCAM-dependent adhesion in antigen-
presenting cells as discussed by Reyes et al. In line with this, tetraspanins of the TspanC8 subgroup,
containing eight cysteine residues in their large extracellular loops, are required for ADAM10
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exit from the endoplasmic reticulum and trafficking to the cell
surface or other membrane compartments (11, 12). ADAM10
is well characterized as the ligand-dependent activator of
Notch proteins, and Mike Tomlinson and colleagues discuss
how TspanC8 members (Tspan5, Tspan10, Tspan14, Tspan15,
Tspan17, and Tspan33) may control ADAM10 activity on
myeloid and lymphoid cells in a specific manner (Matthews
et al.). The most highly expressed TspanC8 in human and
mouse T cells is Tspan14, followed by Tspan5 and Tspan17.
Since both Tspan14 and Tspan5 promote Notch signaling,
it is hypothesized that ADAM10 will have a major role in
thymocyte development. Human and mouse B cells express
high levels of Tspan33 and Tspan14, respectively, which may
regulate Notch2 signaling and/or shedding of other ADAM10
ligands, such as CD23 (the IgEεRII). Some of these questions
can be addressed by investigating newly generated Tspan14 and
Tspan5-knockout mice. The authors also propose that targeting
individual TspanC8 members may provide a novel therapeutic
approach for ADAM10-associated diseases (leukemia, asthma,
atherosclerosis, and Alzheimer’s disease) without the toxicity of
global ADAM10 inhibition.
Tetraspanins on antigen-presenting cells control multiple
different functions, including cell migration, pathogen uptake,
MHC trafficking, immunological synapse formation and
antigen-presentation as reviewed by the group of Saiz et al.
In B cells, tetraspanins (CD37, CD53, CD81) are essential
for B cell receptor signaling, antibody production and
cytokine secretion (Zou et al.). Interestingly, CD37-deficiency
leads to spontaneous B cell lymphoma formation in mice,
and patients with CD37-deficient B cell lymphomas have
inferior clinical outcome than patients with CD37-positive
lymphomas (13).
The pathogenesis of different infectious diseases is also
influenced by different tetraspanin proteins (14). Besides
adhesion and signaling, tetraspanins have been related to
different membrane fusion events. The group of Peter Monk has
explored the role of different tetraspanin members in membrane
fusion of monocytic cells in response to Mycobacterium
tuberculosis infection (Champion et al.). Tetraspanins can also
interfere with different stages of the virus replication cycle. Florin
and Lang evaluate how viruses exploit TEMs for viral entrance
into cells, and subsequent budding and egress. Some viruses
use specific tetraspanins as receptors (for example CD151-HPV,
CD81-HCV) and by compartmentalizing host entry factors. In
addition, viral envelope proteins accumulate in TEMs during
morphogenesis, and induce large assemblies of tetraspanins
and viral transmembrane proteins to facilitate budding. For
example, tetraspanins (CD9, CD63, CD81, CD82) can be
incorporated into the enveloping membrane of virions, such
as HIV, feline immunodeficiency virus, influenza or hepatitis A
virus, indicating that TEMs directly stimulate virus budding and
exit. New evidence shows that HIV-1 replication is stimulated
by CD81 through its direct interaction with the deoxynucleoside
triphosphate phosphohydrolase SAMHD1 (15). Suárez et al.
elaborate on the mechanisms underlying tetraspanin regulation
of HIV-1 replication, which may be exploited to develop
tetraspanin-based therapeutics as a novel strategy to restrict
HIV-1 infection.
Given the plethora of immune functions that are controlled
by tetraspanins, it is maybe not surprising that tetraspanins are
important in anti-tumor immune responses. Even though this
field is rather unexplored, tetraspanins expressed by immune
suppressive cells (such as regulatory T cells, myeloid-derived
suppressor cells) can control immune responses within the
tumor microenvironment as discussed by Schaper and van
Spriel. In addition, tetraspanins have been shown to modulate
cancer metastasis indirectly through exosomes, and by regulating
cellular interactions in the immune system as reflected on by
Vences-Catalán and Levy.
Taken together, although broad in function, the underlying
mechanism by which different tetraspanins accomplish their
function is highly similar. Through their lateral molecular
interactions with immune receptors, enzymes and/or signaling
proteins, tetraspanins are in charge of organizing the protein
landscape at the plasma membrane of immune cells. Evidence
is now accumulating that these protein interactions are dynamic
and likely change upon cell activation. Future research should
provide better insight into the (1) specificity versus redundancy
of individual tetraspanins on immune cell function, and (2)
molecular mechanisms underlying TEM formation and coupling
to signaling transduction pathways. The potency of targeting
tetraspanins is currently under investigations at the (pre-)clinical
level as novel therapeutics for cancer, infectious diseases and
auto-immunity disorders (16, 17).
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